Bed rest or mobilization after rt-PA? A case-crossover study of factors influencing clinical decision making in stroke services

International Journal of Stroke

Volumn 8, Issue 3, 2013, Pages 172-179

  Ha, Jason ^a,b   Churilov, Leonid ^a,b   Linden, Thomas ^a,c   Bernhardt, Julie ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clinical decision making; Recombinant tissue plasminogen activator; Stroke; Very early mobilisation

Indexed keywords

ALTEPLASE;

ARTICLE; AUSTRALIA; BED REST; BRAIN HEMORRHAGE; BRAIN INFECTION; CEREBROVASCULAR ACCIDENT; CHEST INFECTION; CINAHL; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; COMPUTER PROGRAM; CONFUSION; DATA PROCESSING; DEMOGRAPHY; DISEASE SEVERITY; DROWSINESS; FALL RISK; HOSPITAL; HUMAN; HYPOTHESIS; MEDICAL SPECIALIST; MEDLINE; MOBILIZATION; NURSE; PRIORITY JOURNAL; PSYCINFO; SYSTEMATIC REVIEW;

BED REST; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; CROSS-OVER STUDIES; DECISION MAKING; EARLY AMBULATION; FIBRINOLYTIC AGENTS; HUMANS; PILOT PROJECTS; PROFESSIONAL PRACTICE; RECOMBINANT PROTEINS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84875246888     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00660.x     Document Type: Article

References (41)

1. Albers GW, Bates VE, Clark WM. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) Study. JAMA 2000; 283:1145-1150.
2. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (Alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) - results of a double-blind, placebo-controlled, multicenter study. Stroke 2000; 31:811-816.
3. Hacke W, Kaste M, Fieschi C etal. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352:1245-1251.
4. Davis SM, Donnan GA, Parsons MW, Levi C etal. Effects of alteplase beyond 3h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet 2008; 7:299-309.
5. Keyser JD, Gdovinova Z, Uyttenboogaart M, Vroomen P, Luijck GJ. Intravenous alteplase for stroke - beyond the guidelines and in particular clinical situations. Stroke 2007; 38:2612-2618.
6. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. Can multivariable risk-benefit profiling be used to select treatment-favorable patients for thrombolysis in stroke in the 3- to 6-hour time window? Stroke 2006; 37:2963-2969.
7. Selim M, Fink JN, Kumar S etal. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002; 33:2047-2052.
8. Els T, Klisch J, Orszagh M etal. Hyperglycemia in patients with focal cerebral ischemia after intravenous thrombolysis: influence on clinical outcome and infarct size. Cerebrovasc Dis 2002; 13:89-94.
9. Bruno A, Levine S, Frankel M etal. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 2002; 59:669-674.
10. Demchuk AM, Morgenstern LB, Krieger DW etal. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999; 30:34-39.
11. National Stroke Foundation. Clinical Guidelines for Stroke Management. Melbourne, Australia, 2010.
12. Bernhardt J, Dewey H, Collier J etal. A Very Early Rehabilitation Trial (AVERT). Int J Stroke 2006; 1:169-171.
13. National Stroke Foundation. National Stroke Audit Organisational Report Acute Services. Melbourne, Australia, 2007.
14. Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133:144-153.
15. Ludwick R, Wright ME, Zeller RA, Dowding DW, Lauder W, Winchell J. An improved methodology for advancing nursing research - factorial surveys. ANS Adv Nurs Sci 2004; 27:224-238.
16. Lansberg M, Albers G, Wijman C. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis 2007; 24:1-10.
17. Arias M, Smith LN. Early mobilisation of acute stroke patients. J Clin Nurs 2007; 16:282-288.
18. Engelter S, Bonati L, Lyrer P. Intravenous thrombolysis in stroke patients of >80 versus <80years of age - a systematic review across cohort studies. Age Ageing 2006; 35:572-580.
19. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke - subgroup analysis of the NINDS t-PA stroke trial. Stroke 1997; 28:2119-2125.
20. Demchuk A, Hill M, Barber P, Silver B, Patel S, Lavine S. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 2005; 36:2110-2115.
21. Patel S, Levine S, Tilley B etal. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001; 2001:2830-2838.
22. Diserens K, Michel P, Bogousslavsky J. Early mobilisation after stroke: review of the literature. Cerebrovasc Dis 2006; 22(2-3):183-190.
23. Allen C, Glasziou P, Mar CD. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet 1999; 354:1229-1233.
24. Warlow C, Ogston D, Douglas A. Deep venous thrombosis of the legs after stroke: incidence and predisposing factors. BMJ 1976; 1:1178-1181.
25. Asberg K. Orthostattic tolerance training of stroke patients in general medical wards. Scand J Rehabil Med 1989; 21:179-185.
26. Mishra W, Lyden P, Grotta J, Lees K. Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke 2010; 41:2612-2617.
27. Johansson BB. Brain plasticity and stroke rehabilitation: the Willis lecture. Stroke 2000; 31:223-230.
28. Krauss M, Evanoff B, Hitcho E, Ngugi K, Dunagan W, Fischer I. A case-control study of patient, medication, and care related risk factors for inpatient falls. J Gen Intern Med 2005; 20:116-122.
29. Memezawa H, Minamisawa H, Smith M, Siesjo S. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res 1992; 89:67-78.
30. Wojner-Alexandrov A, Garami Z, Chernyshev O, Alexandrov A. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology 2005; 64:1354-1367.
31. Schmitz C (ed.) Lime Survey. 2008.
32. Dillman DA. Mail and Internet Surveys: The Tailored Design Method, 2nd edn. Hoboken, NJ, John Wiley & Sons, 2007.
33. Saqqur M, Molina C, Salam A etal. Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment - a multicenter transcranial doppler study. Stroke 2007; 38:69-74.
34. Grotta JC, Welch KMA, Fagan SC etal. Clinical deterioration following improvement in the NINDS rt-PA stroke trial. Stroke 2001; 32:661-668.
35. Skarin M, Bernhardt J, Sjohom A, Nilsson M, Linden T. 'Better wear out sheets than shoes': a survey of 202 stroke professionals' early mobilisation practices and concerns. Int J Stroke 2011; 6:10-15.
36. Brott T, Lu M, Kothari R etal. Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke 1998; 29:1504-1509.
37. Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke 2002; 33:497-501.
38. Novak V, Chowdhary A, Farrar B etal. Altered cerebral vasoregulation in hypertension and stroke. Neurology 2003; 60:1657-1663.
39. Powers WJ. Acute hypertension after stroke: the scientific basis for treatment decisions. Neurology 1993; 43:461-467.
40. Canadian Stroke Network and the Heart and Stroke Foundation of Canada: Canadian Stroke Strategy. Canadian Best Practice Recommendations for Stroke Care. 2006: Ottawa.
41. The European Stroke Organisation Executive Comittee and the European Stroke Organisation Writing Committee. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. 2008: Germany.